液相色谱-串联质谱联用法测定蜂蜜及水产品中硝基呋喃类抗生素代谢物残留量

采用微量化样品前处理技术,以邻硝基苯甲醛为衍生剂,电喷雾正离子多反应监测方式建立了蜂蜜及水产品中四种硝基呋喃类抗生素代谢物残留量同时测定的液相色谱-串联质谱联用法。方法的检出限为0.02～0.3 ng/g,线性范围均>10~2,线性方程的相关系数>0.997,回收率为79.0％～95.6％。     

树脂预分离氢化物-原子荧光光谱法测定水中的As(Ⅲ)和As(Ⅴ)

建立了As(Ⅲ)、As(V)的树脂分离 氢化物 原子荧光光谱分析方法。利用717阴离子交换树脂选择性的吸附水中的As(Ⅴ),从而实现了对水样中As(Ⅲ)和As(Ⅴ)的分离。考察了溶液的pH和流速以及洗脱剂浓度等条件对分离效果的影响,同时研究了仪器的工作条件、KBH4质量浓度和介质浓度对砷原子荧光强度的影响,并对测定砷时共存离子的干扰和消除进行了探讨。在最佳工作条件下,砷的检出限为0.096μg L,相对标准偏差为2.1%,将该方法应用于水样分析,其回收率为94.7%～107.9%。     

蛋白质组学中基质辅助激光解吸电离的基质研究进展

基质辅助激光解吸电离(MALDI)技术是近年来发展起来的新的质谱离子化技术。本文较为系统地综述了应用于蛋白质组学中的MALDI基质的最新进展以及不同的基质的优缺点及应用范围,并且归纳了其发展趋势。     

吡咯烷二硫代氨基甲酸铵-Ni(Ⅱ)快速共沉淀分离富集和原子吸收光谱法测定痕量铜、铅和镉

研究了用吡咯烷二硫代氨基甲酸铵(APDC)为沉淀剂,以Ni(Ⅱ)为载体离子的共沉淀体系快速共沉淀分离富集铜、铅和镉,并用火焰原子吸收光谱(FAAS)测定的方法。通常情况下,内标元素和载体离子选择不同的元素,本文尝试将Ni既作为载体又作为内标元素。实验证明,该体系在pH=3.0的条件下,能够定量共沉淀试样中的铜、铅和镉。当试液为100 mL时,铜、铅、镉的检出限分别为9.7×10-3、3.3×10-2,1.01×10-3μg.mL-1,加标回收率为95.8%~101.8%,取得了较为满意的结果。本法只需快速收集部分沉淀,与传统的共沉淀方法比较,具有快速、简便、重现性好的优点。     

高效液相色谱/串联质谱法同时测定虾中氯霉素、甲砜霉素和氟甲砜霉素残留量

用高效液相色谱／串联质谱(LC／MS,／MS)同时测定虾中的氯霉素(CAP)、甲砜霉素(TAP)和氟甲砜霉素(FF)。均质后的虾样品,采用碱化乙酸乙酯提取。浓缩提取物经液．液分配(LLP)去除脂肪,C18固相萃取(SPE)柱净化后,采用LC／MS／MS电喷雾电离(ESI),负离子,多反应监测(MRM)模式检测,外标法定量。检出限为：氯霉素和氟甲砜霉素0．01ng/g;甲砜霉素为0．05ng／g。在添加浓度0．1～2．0ng/g范围内,氯霉素回收率为73．9％～96．0％;甲砜霉素回收率为78．6％～99．5％;氟甲砜霉素回收率为74．9％～103．7％;相对标准偏差(RSD)均小于6．4％。     

采用柱切换色谱-离子阱质谱联用法研究复方丹参滴丸中丹参素及其代谢产物

采用柱切换高效液相色谱技术对人血清中的丹参素及其代谢产物进行富集和分离,利用对电喷雾离子阱多级质谱负离子模式进行结构分析。一级流动相为甲醇-水(30：70,V/V),流速0．8mL／min;二级流动相为甲醇-水-甲酸铵(15：85：0．5,V/V/V),流速0．2mL／min;在人血清中检测到丹参素及其代谢产物,并探讨了主要代谢产物乙酰化的丹参素(m/z 240．2)。建立一种复方丹参滴丸中丹参素及其代谢产物在人体内代谢过程的高效分析方法。该方法可用于复方丹参滴丸中丹参素及与其结构类似的其它药物的体内代谢研究。     

壳聚糖富集火焰原子吸收法测定水中痕量铜

采用壳聚糖修饰钨丝基质螺旋卷，直接浸入含有痕量铜的pH5．0的Brltton-Robinson缓冲溶液中，经电磁搅拌富集一定时间后，将其转移至空气／乙炔火焰燃烧器上，利用火焰原子吸收光谱法简便快速测定水中痕量铜。方法的线性范围为2—75μg／L；检出限为0．98μg／L。同一支钨丝螺旋卷重复涂敷壳聚糖富集Cu，RSD(n=6)为2．7％。     

电感耦合等离子体质谱法测定血液和精液中的硼

采用HNO3-H2O2和氨水-甘露醇两种方法处理样品,电感耦合等离子体质谱法（ICP-MS）测定血液和精液中的硼。Be作内标补偿基体效应,并用标准加入法验证了方法的可靠性,标准加入法与外标法测定结果相吻合。在测定B的同时,还可进行Cr、Cu、Cd、Ba、Sr、Mn、Co、Tl、Li、Pb、Zn、Sc、Ti、V、As等多元素测定。两种样品处理方法的测定值呈显著正相关（r=0.99919）。方法检出限为0．11ng／mL（氨水-甘露醇法）,0.06ng／mL（HNO3-H2O2）。已用于测定某硼矿区血液和精液样品中的硼。     

Fast gas chromatography-negative-ion chemical ionization mass spectrometry with microscale volume sample preparation for the determination of benzodiazepines and alpha-hydroxy metabolites, zaleplon and zopiclone in whole blood

Fast gas chromatography/negative-ion chemical ionization mass spectrometric (GC/NICI-MS) assay combined with rapid and nonlaborious sample preparation is presented for the simultaneous determination of benzodiazepines and alpha-hydroxy metabolites, zaleplon and zopiclone in whole blood. The compounds were extracted from 100 microl of whole blood by simultaneous multitube, microscale liquid-liquid extraction (LLE) and derivatized by N-methyl-N-(tert-butyldimethylsilyl)trifluoroacetamide (MTBSTFA), without the need for the time-consuming concentration stage. In the analytical separation, various parameters of fast GC/NICI-MS were applied, e.g. the use of hydrogen as a GC carrier gas, a high carrier gas velocity, a small film thickness of the analytical column, fast MS data acquisition, fast temperature ramping, and high initial and final temperatures of GC column. Sensitive identification, screening and quantitation of 18 compounds of interest were achieved in chromatographic separation in only 4.40 min. Accurate and reproducible results were obtained by using five different and carefully selected deuterated analogues on the basis of the chemical properties of the target analytes. Nevertheless, for alpha-OH-midazolam, and for bromazepam and flunitrazepam at low concentrations, the results can be considered only semiquantitative on the basis of the validation data. The extraction efficiencies ranged from 74.3 to 105.7% and the limits of quantitation (LOQ) from 1 to 100 ng ml(-1). Rapid sample preparation and fast chromatographic separation allowed cost-efficient, reliable and high sample-throughput analyses with a low amount of manual work. The method was fully validated and accredited according to EN ISO/IEC 17025 standards and is applicable for sensitive, reliable and quantitative determination of benzodiazepines, zaleplon and zopiclone, e.g. in clinical and forensic toxicology.     

Simultaneous quantitation of rosuvastatin and gemfibrozil in human plasma by high-performance liquid chromatography and its application to a pharmacokinetic study

A simple, sensitive and specific high-performance liquid chromatography method is described for simultaneous determination of rosuvastatin (RST) and gemfibrozil (GFZ) in human plasma using celecoxib as an internal standard (IS). The assay procedure involved extraction of RST, GFZ and IS from plasma into acetonitrile. Following separation and evaporation of the organic layer the residue was reconstituted in the mobile phase and injected onto an X-Terra C(18) column (4.6 x 150 mm, 5.0 microm). The chromatographic run time was less than 20 min using flow gradient (0.0-1.60 mL/min) with a mobile phase consisting of 0.01 M ammonium acetate:acetonitrile:methanol (50:40:10, v/v/v) and UV detection at 275 nm. Nominal retention times of RST, GFZ and IS were 6.7, 13.9 and 16.4 min, respectively. Absolute recovery of both analytes and IS was greater than 90%. The lower limit of quantification (LLOQ) of RST and GFZ was 0.03 and 0.30 microg/mL, respectively. Linearity was excellent (r(2) = 0.999) in the 0.03-10 microg/mL and 0.3-100 microg/mL ranges for RST and GFZ, respectively. The inter- and intra-day precisions in the measurement of RST quality control (QC) samples 0.03, 0.09, 2.50 and 8.00 microg/mL were in the range 2.37-9.78% relative standard deviation (RSD) and 0.92-10.08% RSD, respectively. Similarly, the inter- and intra-day precisions in the measurement of GFZ quality control (QC) samples 0.30, 0.90, 25.0 and 80.0 microg/mL were in the ranges 2.79-6.27 and 0.96-9.69% RSD, respectively. Accuracies in the measurement of QC samples for RST and GFZ were in the range 85.43-107.23 and 84.98-102.35% respectively, of the nominal values. RST and GFZ were stable in the array of stability studies viz., bench-top, auto-sampler and freeze-thaw cycles. Stability of RST and GFZ was established for 1 month at -80C. The application of the assay in an oral pharmacokinetic study in rats co-administered with RST and GFZ is described.